Kaizen Financial Strategies’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.75M Sell
1,464
-116
-7% -$119K 0.57% 35
2026
Q1
$1.43M Sell
1,580
-225
-12% -$228K 0.6% 34
2025
Q4
$1.94M Sell
1,805
-418
-19% -$400K 0.86% 23
2025
Q3
$2.08M Buy
2,223
+170
+8% +$127K 0.94% 22
2025
Q2
$1.6M Buy
2,053
+1,240
+153% +$964K 0.81% 24
2025
Q1
$671K Buy
813
+114
+16% +$94.9K 0.39% 43
2024
Q4
$540K Sell
699
-338
-33% -$280K 0.31% 59
2024
Q3
$919K Buy
1,037
+629
+154% +$566K 0.53% 34
2024
Q2
$322K Buy
+408
New +$326K 0.2% 85

Other funds holding LLY

Kaizen Financial Strategies's LLY Position: Q2 2026 in Review

Kaizen Financial Strategies reduced its Eli Lilly (LLY) stake by 7.3% in Q2 2026, selling an estimated $119K and leaving 1,464 shares worth $1.75M. The position accounts for 0.57% of the portfolio, ranked #35.

Kaizen Financial Strategies first reported a position in LLY in Q2 2024 and has held it in 9 quarters since. The position peaked at $2.08M in Q3 2025. 4,630 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Kaizen Financial Strategies held 1,464 shares of Eli Lilly worth $1.75M as of Q2 2026.
  • Kaizen Financial Strategies sold 116 Eli Lilly shares in Q2 2026, an estimated $119K.
  • Eli Lilly made up 0.57% of Kaizen Financial Strategies's portfolio in Q2 2026, its #35 holding.
  • Kaizen Financial Strategies first reported a position in Eli Lilly in Q2 2024 and has held it in 9 quarters since.
  • Kaizen Financial Strategies's Eli Lilly position peaked at $2.08M in Q3 2025.
  • 4,630 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Kaizen Financial Strategies's 13F filing for Q2 2026, filed 30 Jul 2026.